Literature DB >> 30485769

Mutagenesis in Norovirus in Response to Favipiravir Treatment.

Christopher Ruis1, Li-An K Brown2, Sunando Roy1, Claire Atkinson1, Rachel Williams1, Siobhan O Burns1, Erika Yara-Romero1, Michael Jacobs2, Richard Goldstein1, Judith Breuer1, David M Lowe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30485769     DOI： 10.1056/NEJMc1806941

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Norovirus in health care and implications for the immunocompromised host.

Authors:  Pearlie P Chong; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

Review 2.  Epidemiology, Clinical Features, and Unusual Complications of Norovirus Infection in Taiwan: What We Know after Rotavirus Vaccines.

Authors:  Meng-Che Lu; Sheng-Chieh Lin; Yi-Hsiang Hsu; Shih-Yen Chen
Journal:  Pathogens       Date:  2022-04-09

Review 3.  Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy.

Authors:  Marcella Bassetto; Jana Van Dycke; Johan Neyts; Andrea Brancale; Joana Rocha-Pereira
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

4.  Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study.

Authors:  Romy Kerber; Eva Lorenz; Sophie Duraffour; Daouda Sissoko; Martin Rudolf; Anna Jaeger; Sekou Ditinn Cisse; Alseny-Modet Camara; Osvaldo Miranda; Carlos M Castro; Joseph Akoi Bore; Fara Raymond Koundouno; Johanna Repits; Babak Afrough; Beate Becker-Ziaja; Julia Hinzmann; Marc Mertens; Ines Vitoriano; Christopher Hugh Logue; Jan-Peter Böttcher; Elisa Pallasch; Andreas Sachse; Amadou Bah; Mar Cabeza-Cabrerizo; Katja Nitzsche; Eeva Kuisma; Janine Michel; Tobias Holm; Elsa Gayle Zekeng; Lauren A Cowley; Isabel Garcia-Dorival; Nicole Hetzelt; Jonathan Hans Josef Baum; Jasmine Portmann; Lisa Carter; Rahel Lemma Yenamaberhan; Alvaro Camino; Theresa Enkirch; Katrin Singethan; Sarah Meisel; Antonio Mazzarelli; Abigail Kosgei; Liana Kafetzopoulou; Natasha Y Rickett; Livia Victoria Patrono; Luam Ghebreghiorghis; Ulrike Arnold; Géraldine Colin; Sylvain Juchet; Claire Levy Marchal; Jacques Seraphin Kolie; Abdoul Habib Beavogui; Stephanie Wurr; Sabrina Bockholt; Ralf Krumkamp; Jürgen May; Kilian Stoecker; Erna Fleischmann; Giuseppe Ippolito; Miles W Carroll; Lamine Koivogui; N'Faly Magassouba; Sakoba Keita; Céline Gurry; Patrick Drury; Boubacar Diallo; Pierre Formenty; Roman Wölfel; Antonino Di Caro; Martin Gabriel; Xavier Anglaret; Denis Malvy; Stephan Günther
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

5.  The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.

Authors:  Daniel Enosi Tuipulotu; Tulio M Fumian; Natalie E Netzler; Jason M Mackenzie; Peter A White
Journal:  Viruses       Date:  2019-05-30       Impact factor: 5.048

6.  Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides.

Authors:  Raquel Navarro Sempere; Armando Arias
Journal:  Viruses       Date:  2019-06-17       Impact factor: 5.048

7.  A comprehensive characterization of chronic norovirus infection in immunodeficient hosts.

Authors:  Li-An K Brown; Christopher Ruis; Ian Clark; Sunando Roy; Julianne R Brown; Adriana S Albuquerque; Smita Y Patel; Joanne Miller; Mohammed Yousuf Karim; Samir Dervisevic; Jennifer Moore; Charlotte A Williams; Juliana Cudini; Fernando Moreira; Penny Neild; Suranjith L Seneviratne; Sarita Workman; Christos Toumpanakis; Claire Atkinson; Siobhan O Burns; Judith Breuer; David M Lowe
Journal:  J Allergy Clin Immunol       Date:  2019-08-13       Impact factor: 10.793

8.  Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.

Authors:  Suzanne J F Kaptein; Sofie Jacobs; Lana Langendries; Laura Seldeslachts; Sebastiaan Ter Horst; Laurens Liesenborghs; Bart Hens; Valentijn Vergote; Elisabeth Heylen; Karine Barthelemy; Elke Maas; Carolien De Keyzer; Lindsey Bervoets; Jasper Rymenants; Tina Van Buyten; Xin Zhang; Rana Abdelnabi; Juanita Pang; Rachel Williams; Hendrik Jan Thibaut; Kai Dallmeier; Robbert Boudewijns; Jens Wouters; Patrick Augustijns; Nick Verougstraete; Christopher Cawthorne; Judith Breuer; Caroline Solas; Birgit Weynand; Pieter Annaert; Isabel Spriet; Greetje Vande Velde; Johan Neyts; Joana Rocha-Pereira; Leen Delang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-09       Impact factor: 11.205

Review 9.  Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.

Authors:  Kimiyasu Shiraki; Tohru Daikoku
Journal:  Pharmacol Ther       Date:  2020-02-22       Impact factor: 12.310

Review 10.  Norovirus in Cancer Patients: A Review.

Authors:  Divya Samantha Kondapi; Sasirekha Ramani; Mary K Estes; Robert L Atmar; Pablo C Okhuysen
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.